Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

ATNMATNM
Showing 5 of 11 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in ACTINIUM PHARMACEUTICALS INC

TWO SIGMA INVESTMENTS, LP holds 259,179 shares of ATNM (ACTINIUM PHARMACEUTICALS INC), worth $253,995 as of 2026-Q2. The position was decreased (-23.1% shares). ATNM represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$253,995

Current Shares

259,179

Total Value Change

+$188,832

Total Shares Change

+212,634

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
259,179
-23.1%
$253,9950.0%$0.98
0
2026-Q1
Increased
337,168
+60.8%
$335,5830.0%$1.11
34
2025-Q4
Decreased
209,692
-10.5%
$285,1810.0%$1.41
0
2025-Q3
Increased
234,293
+403.4%
$374,8690.0%$1.62
38
2025-Q2
New
46,545
-
$65,1630.0%$1.42
29

Other major holders of ATNM: BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used